Concepedia

Author

Lorraine Soisson

United States Agency for International Development

Also Known As

L A Soisson, L.A. Soisson, Lorraine A Soisson, Lorraine A. Soisson, Lorraine Soisson, Soisson, Lorraine

52

Publications

3K

Citations

26

H-Index

28

Concepts

All Affiliations

United States Agency for International DevelopmentWalter Reed Army Institute of ResearchGlaxoSmithKline (Belgium)Naval Medical Research CommandUniversity of Maryland, Baltimore
LS

About

Lorraine Soisson is an author at United States Agency for International Development specializing in immunology, vaccination, and malaria.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

11

533

2

Immunology

10

11

533

3

Epidemiology

1

1

15

4

Emerging Infectious Diseases

1

1

15

5

Host Resistance

1

1

15

Lorraine Soisson

×

38

Publications

3K

Citations

26

H-Index

YearCitations

A Field Trial to Assess a Blood-Stage Malaria Vaccine

Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly,

New England Journal of Medicine

2011

358

Blood Stage Malaria Vaccine Eliciting High Antigen-Specific Antibody Concentrations Confers No Protection to Young Children in Western Kenya

Bernhards Ogutu, Odika J. Apollo, Denise McKinney,

PLoS ONE

2009

341

Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A

Michele Spring, James F. Cummings, Christian F. Ockenhouse,

PLoS ONE

2009

207

Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial

Mahamadou A. Théra, Ogobara K. Doumbo, Drissa Coulibaly,

PLoS ONE

2008

175

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination

Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett,

Med

2021

156

DNA Prime/Adenovirus Boost Malaria Vaccine Encoding P. falciparum CSP and AMA1 Induces Sterile Protection Associated with Cell-Mediated Immunity

Ilin Chuang, Martha Sedegah, Susan Cicatelli,

PLoS ONE

2013

139

Demonstration of the Blood-Stage<i>Plasmodium falciparum</i>Controlled Human Malaria Infection Model to Assess Efficacy of the<i>P. falciparum</i>Apical Membrane Antigen 1 Vaccine, FMP2.1/AS01

Ruth Payne, Kathryn H. Milne, Sean C. Elias,

The Journal of Infectious Diseases

2016

113

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research

Mark E. Polhemus, Alan J. Magill, James F. Cummings,

Vaccine

2007

100

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

José A. Stoute, Joash Gombe, Mark R. Withers,

Vaccine

2005

100

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine☆

Christian F. Ockenhouse, Evelina Angov, Kent E. Kester,

Vaccine

2005

95

Page 1